Zobrazeno 1 - 10
of 71
pro vyhledávání: '"John M. Rabkin"'
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 19(5)
Autor:
Deepak V. Gopal, David Scott, Ken D. Flora, John M. Rabkin, Susan L. Orloff, Craig S. Broberg, Christopher L. Corless, Avital Y. O’Glasser, Stephen C. Rayhill, Crispin H. Davies, Jonathan M. Schwartz, John M. Ham, Atif Zaman, Anna Sasaki
Publikováno v:
Clinical Transplantation. 24:643-651
O’Glasser AY, Scott DL, Corless CL, Zaman A, Sasaki A, Gopal DV, Rayhill SC, Orloff SL, Ham JM, Rabkin JM, Flora K, Davies CH, Broberg CS, Schwartz JM. Hepatic and cardiac iron overload among patients with end-stage liver disease referred for liver
Publikováno v:
Journal of Cardiac Failure. 14:198-202
Background Young severely obese patients with advanced heart failure may not be suitable candidates for cardiac transplantation because of surgical morbidity and availability of adequately sized donor hearts. Methods and Results We report 2 patients
Autor:
John M. Rabkin, Jan Lerut, Maurizio Muraca, Daniel S. Pratt, Christoph E. Broelsch, Lawrence P. McChesney, Ronald W. Busuttil, Philip J. Rosenthal, Brendan M. McGuire, Philip T. Lavin, Bernard de Hemptinne, Joan Manuel Salmerón, Barry A. Solomon, Jeffrey H. Fair, Elizabeth A. Fagan, Jan Schulte am Esch, Manuel de la Mata, Zorina Pitkin, Mauro Salizzoni, Scott L. Nyberg, Herold J. Metselaar, Achilles A. Demetriou, Gregory T. Everson, Anthony C. Stevens, Robert S. Brown
Publikováno v:
Annals of Surgery, 239(5), 660-670. Lippincott Williams & Wilkins
Objective: The HepatAssist liver support system is an extracorporeal porcine hepatocyte-based bioartificial liver (BAL). The safety and efficacy of the BAL were evaluated in a prospective, randomized, controlled, multicenter trial in patients with se
Publikováno v:
Journal of Clinical Gastroenterology. 37:344-347
UNLABELLED Speculation that primary sclerosing cholangitis (PSC) may recur in the transplanted liver is based on the relative increase in frequency of biliary abnormalities and histologic evidence of periportal fibrosis without other causes. A recent
Publikováno v:
Liver Transplantation. 8:313-322
Retransplantation already accounts for 10% of all liver transplants performed, and this percentage is likely to increase as patients live long enough to develop graft failure from recurrent disease. Overall, retransplantation is associated with signi
Autor:
Henri Bismuth, Göran Klintmalm, Jeffrey Punch, Munci Kalayoglu, Alan Langnas, Russell H. Wiesner, Richard B. Freeman, Richard Mamelok, Paul McMaster, Gary Levy, Whedy Wang, John M. Rabkin, Peter Neuhaus, Sue V. McDiarmid
Publikováno v:
Liver Transplantation. 7:442-450
Acute hepatic allograft rejection occurs in approximately 50% to 60% of the patients undergoing liver transplantation. In this study, we compared the rate of acute rejection in liver transplant recipients randomized in a double-blind comparative stud
Publikováno v:
Journal of Vascular and Interventional Radiology. 11:919-929
PURPOSE To evaluate patency of refractory benign biliary strictures in liver transplant patients treated with retrievable stentgrafts. MATERIALS AND METHODS Eight male liver transplant patients who ranged in age from 42 to 52 years developed nine sym
Autor:
John M. Rabkin, Hugo R. Rosen, Ken D. Flora, Kent G. Benner, Christopher L. Corless, Susan L Oroloff, Ali J. Olyaei
Publikováno v:
The American Journal of Surgery. 179:426-430
Invasive fungal infection is associated with increased morbidity and mortality following orthotopic liver transplantation (OLTx). Understanding the risk factors associated with fungal infection may facilitate identification of high-risk patients and
Autor:
Cynthia R. Wagner, Mark S. Orloff, Susan L. Orloff, Qiang Yin, John M. Rabkin, Christopher L. Corless
Publikováno v:
Transplantation. 69:1295-1303
Background. The major impediment to success in solid organ transplantation is chronic rejection (CR). The characteristic lesion of CR is transplant vascular sclerosis (TVS). Although the mechanism of TVS is thought to have an immunologic basis, in hu